← Back to headlines
Vertex Announces Positive Week 36 Interim Analysis Results for Primary and All Secondary Endpoints in the RAINIER Phase 3 Trial of Povetacicept in Adults With IgA Nephropathy - TradingView
Vertex Announces Positive Week 36 Interim Analysis Results for Primary and All Secondary Endpoints in the RAINIER Phase 3 Trial of Povetacicept in Adults With IgA Nephropathy TradingView
9 Mar, 21:34 — 9 Mar, 21:34
Related Stories
US Study Reveals AI Applications Over-Validate Users, Potentially Impairing Judgment
12m ago
WHO Condemns Israeli Strike Killing Lebanese Rescuer in Ambulance
16m ago
Over 30 Bodies, Including 25 Children, Discovered in Kenyan Mass Grave
19m ago
Jefferies Maintains 'Buy' Rating on Eli Lilly and Company (LLY)
25m ago